Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Randomized Study of 2% Miconazol Versus 4% Hydroquinone in the Treatment for Melasma.

NCT01661556 is registered in ClinicalTrials.gov with Universidad Autonoma de San Luis Potosí as lead sponsor.

NCT NCT01661556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01661556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Randomized Study of 2% Miconazol Versus 4% Hydroquinone in the Treatment for Melasma.
Lead sponsor
Universidad Autonoma de San Luis Potosí
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2011
Completion date
December 31, 2015
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melasma